This review highlights ECMO's role in oxygenation and decarboxylation in ARDS patients, suggesting effective management strategies.
This review examines the role of extracorporeal membrane oxygenation (ECMO) in the management of severe acute respiratory distress syndrome (ARDS), emphasizing its contribution to lung-protective ventilation by optimizing oxygenation and ensuring optimal decarboxylation. Key determinants of oxygen delivery during ECMO include circuit blood flow, cannula size and positioning, and hemoglobin concentration. Strategies for troubleshooting oxygenation issues, including recirculation, increased oxygen consumption, and oxygenator dysfunction, are reviewed. In contrast, carbon dioxide removal (decarboxylation), which is efficiently achieved by ECMO circuits, is primarily influenced by sweep gas flow and the patient's systemic PaCO₂. Effective management of these factors is crucial for ensuring optimal ECMO support, enabling ultra-protective lung ventilation, and improving outcomes in critically ill patients with severe ARDS.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: